167 related articles for article (PubMed ID: 31696204)
1. CXCR3 from chemokine receptor family correlates with immune infiltration and predicts poor survival in osteosarcoma.
Tang Y; Gu Z; Fu Y; Wang J
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31696204
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of STAT5A predicts poor prognosis in osteosarcoma.
Guo Z; Tang Y; Fu Y; Wang J
Pathol Res Pract; 2019 Mar; 215(3):519-524. PubMed ID: 30638860
[TBL] [Abstract][Full Text] [Related]
3. Impact of chemokine receptor CXCR3 on tumor-infiltrating lymphocyte recruitment associated with favorable prognosis in advanced gastric cancer.
Li K; Zhu Z; Luo J; Fang J; Zhou H; Hu M; Maskey N; Yang G
Int J Clin Exp Pathol; 2015; 8(11):14725-32. PubMed ID: 26823797
[TBL] [Abstract][Full Text] [Related]
4. Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer.
Chen F; Yin S; Niu L; Luo J; Wang B; Xu Z; Yang G
Genet Test Mol Biomarkers; 2018 Jan; 22(1):35-42. PubMed ID: 29266971
[TBL] [Abstract][Full Text] [Related]
5. Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer.
Ohri CM; Shikotra A; Green RH; Waller DA; Bradding P
BMC Cancer; 2010 Apr; 10():172. PubMed ID: 20429924
[TBL] [Abstract][Full Text] [Related]
6. Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer.
Chen F; Yuan J; Yan H; Liu H; Yin S
Biomed Res Int; 2019; 2019():6832867. PubMed ID: 31240220
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells.
Ocaña E; Delgado-Pérez L; Campos-Caro A; Muñóz J; Paz A; Franco R; Brieva JA
Haematologica; 2007 Mar; 92(3):349-56. PubMed ID: 17339184
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma.
Ren Z; Liang S; Yang J; Han X; Shan L; Wang B; Mu T; Zhang Y; Yang X; Xiong S; Wang G
Tumour Biol; 2016 Apr; 37(4):5089-96. PubMed ID: 26546437
[TBL] [Abstract][Full Text] [Related]
9. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
10. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
[TBL] [Abstract][Full Text] [Related]
11. Development of a prognostic gene signature based on an immunogenomic infiltration analysis of osteosarcoma.
Yu Y; Zhang H; Ren T; Huang Y; Liang X; Wang W; Niu J; Han Y; Guo W
J Cell Mol Med; 2020 Oct; 24(19):11230-11242. PubMed ID: 32820615
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
13. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
14. Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients.
Zhang Z; Liu C; Liang T; Yu C; Qin Z; Zhou X; Xue J; Zeng H; Lu Z; Xu G; Wang Z; Chen J; Jiang J; Zhan X
Medicine (Baltimore); 2020 Nov; 99(46):e23251. PubMed ID: 33181717
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
[TBL] [Abstract][Full Text] [Related]
16. Development of an immune-related prognostic index associated with osteosarcoma.
Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
[TBL] [Abstract][Full Text] [Related]
17. The expression of chemokine receptors CXCR3 and CXCR4 in predicting postoperative tumour progression in stages I-II colon cancer: a retrospective study.
Du C; Yao Y; Xue W; Zhu WG; Peng Y; Gu J
BMJ Open; 2014; 4(8):e005012. PubMed ID: 25232565
[TBL] [Abstract][Full Text] [Related]
18. CXCR3 is induced early on the pathway of CD4+ T cell differentiation and bridges central and peripheral functions.
Rabin RL; Alston MA; Sircus JC; Knollmann-Ritschel B; Moratz C; Ngo D; Farber JM
J Immunol; 2003 Sep; 171(6):2812-24. PubMed ID: 12960302
[TBL] [Abstract][Full Text] [Related]
19. Identification of two immune subtypes in osteosarcoma based on immune gene sets.
Yang M; Cao Y; Wang Z; Zhang T; Hua Y; Cai Z
Int Immunopharmacol; 2021 Jul; 96():107799. PubMed ID: 34162161
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma.
Huang X; Hu H; Zhang W; Shao Z
J Cell Physiol; 2019 Aug; 234(10):18408-18414. PubMed ID: 30891768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]